In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure.
about
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediateGenetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian exampleStructural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor.Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.HIV-1 Protease and Substrate Coevolution Validates the Substrate Envelope As the Substrate Recognition Pattern.Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.
P2860
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
In vitro evolution of the huma ...... owing prolonged drug exposure.
@en
In vitro evolution of the huma ...... owing prolonged drug exposure.
@nl
type
label
In vitro evolution of the huma ...... owing prolonged drug exposure.
@en
In vitro evolution of the huma ...... owing prolonged drug exposure.
@nl
prefLabel
In vitro evolution of the huma ...... owing prolonged drug exposure.
@en
In vitro evolution of the huma ...... owing prolonged drug exposure.
@nl
P2093
P2860
P1476
In vitro evolution of the huma ...... owing prolonged drug exposure.
@en
P2093
M P De Pasquale
P Citterio
S Kurtagic
S La Seta Catamancio
P2860
P304
P356
10.1128/JCM.39.3.1124-1129.2001
P407
P577
2001-03-01T00:00:00Z